BPMC
Blueprint Medicines Corp
Price:  
95.45 
USD
Volume:  
960,286.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BPMC WACC - Weighted Average Cost of Capital

The WACC of Blueprint Medicines Corp (BPMC) is 7.8%.

The Cost of Equity of Blueprint Medicines Corp (BPMC) is 7.75%.
The Cost of Debt of Blueprint Medicines Corp (BPMC) is 7.00%.

Range Selected
Cost of equity 6.70% - 8.80% 7.75%
Tax rate 0.30% - 0.40% 0.35%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.7% - 8.8% 7.8%
WACC

BPMC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.62 0.71
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.70% 8.80%
Tax rate 0.30% 0.40%
Debt/Equity ratio 0.03 0.03
Cost of debt 7.00% 7.00%
After-tax WACC 6.7% 8.8%
Selected WACC 7.8%